Cassiopea is a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action to address long-standing and essential dermatological conditions, ...

While Cassiopea’s Winlevi (clascoterone) is likely to be FDA approved in moderate-to-severe acne, it is at risk of diminishing clinician/patient interest following initially optimistic early uptake, ...

In this analysis, my focus will be on developing a perspective on Cassiopea Sp.A.’s (SWX:SKIN) latest ownership structure, a less discussed, but important factor. When it comes to ownership structure ...

It’s been decades since a novel acne treatment hit the scene, but that’s set to change with Cassiopea’s approval for Winlevi. The FDA on Thursday approved the new prescription acne medication, set for ...

Lainate, Italy - September 10, 2021: Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to ...

LAINATE, Italy, Nov. 8, 2019 /PRNewswire/ -- Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to ...

Swiss-listed drugmaker Cassiopea said on Thursday it won approval for its first medicine, an acne treatment called Winlevi, from the U.S. Food and Drug Administration, setting the stage for a likely ...

Add Yahoo as a preferred source to see more of our stories on Google. ZURICH (Reuters) - Swiss-listed drugmaker Cassiopea said on Thursday it won approval for its first medicine, an acne treatment, ...

The Milan, Italy-based pharmaceutical company Cassiopea S.p.A. has created a new therapeutic topical drug class to treat acne. But that’s just the beginning of its story. With its US subsidiary ...

ZURICH (Reuters) - Swiss-listed drugmaker Cassiopea said on Thursday it won approval for its first medicine, an acne treatment, from the U.S. Food and Drug Administration, setting the stage for a ...